← Leaderboards
Ernest C. Borden
Cleveland Clinic Foundation
$3,599,637
Attributed
$3,599,637
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $829.8K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$3,599,637 · 5
By mechanism
R01$3,354,746 · 3
M01$244,891 · 2
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Mark W Jackson$14,843,139
- Andrew Charles Larner$7,457,114
- George Robert Stark$19,236,463
- Daniel J Lindner$2,056,260
- Douglas W Leaman$2,801,286
Others in their field
Top investigators on “Gene Induction /Repression”
- Stephen G Young · J. David Gladstone Institutes$9,517,509
- Dean Sheppard · University Of California San Francisco$8,235,740
- Judy Lieberman · Boston Children'S Hospital$6,772,749
- Tucker O Collins · Brigham And Women'S Hospital$6,135,718
- Michael Karin · University Of California, San Diego$5,783,991
- Anjana Rao · Immune Disease Institute, Inc.$5,529,176
Research focus
Gene Induction /RepressionInterferon AlphaNeoplasm /Cancer ImmunotherapyHuman Therapy EvaluationHuman SubjectApoptosisPatient Oriented ResearchMetastasisClinical Trial Phase IMultiple MyelomaBiological Signal TransductionRenal Cell CarcinomaCell Growth RegulationNeoplasm /Cancer GeneticsNeoplasm /Cancer PharmacologyMonocyteNorthern BlottingsMelanomaInterferon BetaMhc Class Ii AntigenFunctional /Structural GenomicsLigandsMicroarray TechnologyNuclear Factor Kappa Beta
Grant awards (14)
SHP1 Targeted Inhibition by Stibogluconate for Melanoma$239,656
R01 · FY2007 · CA · contact PI
SHPI Targeted Inhibition by Stibogluconate for Melanoma$219,390
R01 · FY2006 · CA · contact PI
PHASE I EVALUATION OF SODIUM STIBOGLUICONATE$48,715
M01 · FY2006 · RR · contact PI
Increasing Effects of Interferons for Melanoma$340,425
R01 · FY2005 · CA
Clinical and Cellular Effects of Interferon alfa 1$317,475
R01 · FY2005 · CA
CLINICAL AND CELLULAR EFFECTS OF INTERFERON$171,871
M01 · FY2005 · RR
Increasing Effects of Interferons for Melanoma$340,425
R01 · FY2004 · CA
Clinical and Cellular Effects of Interferon alfa 1$317,475
R01 · FY2004 · CA
Clinical and Cellular Effects of Interferon$24,305
M01 · FY2004 · RR
Increasing Effects of Interferons for Melanoma$329,300
R01 · FY2003 · CA
Clinical and Cellular Effects of Interferon alfa 1$307,100
R01 · FY2003 · CA
Increasing Effects of Interferons for Melanoma$329,300
R01 · FY2002 · CA
Clinical and Cellular Effects of Interferon alfa 1$307,100
R01 · FY2002 · CA
Clinical and Cellular Effects of Interferon alfa 1$307,100
R01 · FY2001 · CA